What Price Salmon?

Credit: OAR/National Undersea Research Program (NURP) With the year-end release of a final decision on how to proceed toward saving wild Northwest salmon from extinction, the Clinton Administration left implementation of its long-awaited plan to the incoming Republicans. For years, researchers have struggled under a glare of media exposure to resolve a central issue: should four hydroelectric dams in Washington be removed to help save the fish? The conclusion is no, not yet, but a scientific div

Written bySteve Bunk
| 11 min read

Register for free to listen to this article
Listen with Speechify
0:00
11:00
Share

Credit: OAR/National Undersea Research Program (NURP)


With the year-end release of a final decision on how to proceed toward saving wild Northwest salmon from extinction, the Clinton Administration left implementation of its long-awaited plan to the incoming Republicans. For years, researchers have struggled under a glare of media exposure to resolve a central issue: should four hydroelectric dams in Washington be removed to help save the fish? The conclusion is no, not yet, but a scientific divide remains over how close extinction is and over the potential effectiveness of various alternatives to dam removal that the plan recommends.

President George W. Bush campaigned strongly against decommissioning the dams, while pledging support for other protection efforts. Anti-dam activists haven't ruled out legal action, as both sides of the debate continue to assert that the "best science" supports them. For researchers, the salmon story provides a multifaceted study in the difficulties of ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies